baber/WOPTO huggingface dataset:
Patent AT-E226670-T1 (AT)
Inventor: GESSNER DIETER
IPC: D04H1/00
Filed: 1998-08-12
Granted: 2002-11-15
Abstract: The facade cladding has a body of mineral wool, with the fiber alignment at right angles to its laying surface at the rear side. The visible surface is given a contoured structure by dry embossing. The mineral wool cladding (27) is produced in one or more layers (36,37), with the fibers standing upright. The outer surface of erect fibers is shaped by dry embossing, without added shape stabilizers or fluids. The embossing pressure forms depressed concave zones (26) where the fiber ends are either broken or shaped with an irreversible distortion. The broken/distorted fiber ends are compressed together at the outer surface of the material to give a smooth embossed pattern surface. The compressed zones have a density of 50-170 kg/m<3>. Before embossing, the fibers pass through an impregnation and hardening station to fix their alignment. A closed profile is worked into the surface areas where the embossing has imposed a concave surface structure, and an open profile can be embossed alongside. The cladding material production is continuous, using a mineral wool web passed through the processing stages. After embossing, the cladding material is cut to size and shape.
Patent AT-E246455-T1 (AT)
Inventor: STAHL BERND
IPC: A23L1/09
Filed: 1998-01-16
Granted: 2003-08-15
Abstract: The invention relates to a carbohydrate mixture for dietetic foods administered by the enteral or parenteral route and pharmaceuticals, characterized in that said mixture consists of (a) monosaccharide(s), (b) oligosaccharide(s) (at most hexasaccharides) and (c) polysaccharide(s) (at least heptasaccharides), where the mixing ratio a, b, c, in respect of weight, is: alpha=1, b=40 to 1000, and c=1 to 50, and in that it contains at least 1 weight percent of fucose occurring either freely and/or bound to an oligosaccharide and/or a polysaccharide. According to the invention, the carbohydrate mixture has both a nutritional and a biological effect which is considerably greater than the corresponding action of the individual constituents.
Patent AT-E298423-T1 (AT)
Inventor: SHIMIZU HIROYUKI
IPC: G01N33/68
Filed: 1998-03-31
Granted: 2005-07-15
Abstract: A method for inhibiting the degradation of mammalian natriuretic peptides, in particular, BNP by using containers wherein the face coming into contact with specimens are made of a material capable of inhibiting the activation of a substance degrading peptides. This method makes it possible to collect specimens for measuring natriuretic peptides stably and conveniently . Also provided is a method for measuring natriureitc peptides by using these containers.
Patent AT-E246731-T1 (AT)
Inventor: BOSWORTH BRAD T
IPC: C12N15/09
Filed: 1998-05-20
Granted: 2003-08-15
Abstract: The present invention provides non-invasive methods and compositions to differentiate, with a high level of sensitivity and specificity, swine that are genetically susceptible to diseases associated with F18 E. coli infection, from resistant swine. DNA polymorphisms in the swine alpha (1,2) fucosyltransferase 1 (FUT1) gene were used to differentiate resistant from susceptible swine. The invention includes a polypeptide with amino acid substitutions, encoded by the nucleotide polymorphisms, a molecular diagnostic assay, and a kit for the differentiation, of E. coli F18-adhesion resistant, heterozygous (carrier) and homozygous susceptible pigs. The molecular test identifies susceptibility to oedema disease and postweaning diarrhea with high sensitivity and specificity, therefore, is useful to swine breeder in their effort to enhance for resistance. Information on the polymorphisms of the present invention provides insight into causation and treatment of E. coli associated intestinal disorders.
Patent AT-E226770-T1 (AT)
Inventor: RICKARD ROBIN PAUL
IPC: H04B3/54
Filed: 1998-06-08
Granted: 2002-11-15
Abstract: A power line communications system comprises a power line (120) for distributing electricity to a plurality of premises (S1, S2...) and communication stations (TRX) coupled to the power line at the premises. Data is transmitted to/from stations over the power line using a packet data communications protocol. Apparatus at premises can convert signals between a first protocol, used on the power line, and a second protocol e.g. Ethernet for transferring data to a communications station.
Patent AT-E205648-T1 (AT)
Inventor: PAMMER RAIMUND
IPC: H04B10/114
Filed: 1998-07-09
Granted: 2001-09-15
Abstract: A data receiver circuit for infrared signals, in particular for toll systems on roads, comprises several infrared detectors (5) the signals of which are supplied to a summing circuit so as to increase the useful power while suppressing interfering signals. To improve the signal/noise ratio, it is provided that several input circuits are provided with an infrared detector (5a, 5b to 5n) each and with an associated separate amplifier (6a, 6b to 6n), and that these input circuits are connected in parallel to the summing circuit (7).
Patent AT-E260997-T1 (AT)
Inventor: COLE ROBERT S
IPC: C22F1/00
Filed: 1998-08-26
Granted: 2004-03-15
Abstract: A high purity cobalt sputter target is disclosed which contains a face centered cubic (fcc) phase and a hexagonal close packed (hcp) phase, wherein the value of the ratio of X-ray diffraction peak intensity, Ifcc(200)/Ihcp(10 1), is smaller than the value of the same ratio in a high purity cobalt material obtained by cooling fcc cobalt to room temperature from the high temperature at which it is molten. High purity cobalt is defined as having an oxygen content of not more than 500 ppm, a Ni content of not more than 200 ppm, contents of Fe, Al and Cr of not more than 50 ppm each, and Na and K of less than 0.5 ppm. The disclosed sputter target is manufactured by subjecting the material to cold-working treatments (less than 4221C). Annealing the material, at a temperature in the range 300-4221C for several hours, between cold working treatments significantly increases the amount of cold work which could be imparted into the material. The high purity cobalt is deformed in such a way so as to cause the (0002) hcp plane to be tilted between 10-351 from the target normal. The aforementioned phase proportions and crystallographic texture significantly improves the sputtering efficiency and material utilization.
Patent AT-E283357-T1 (AT)
Inventor: WIELAND ILSE
IPC: C12N15/09
Filed: 1999-02-18
Granted: 2004-12-15
Abstract: An isolated nucleic acid molecule (I) (del-27) is new. An isolated nucleic acid molecule (I) (del-27) is new: (a) comprises nucleic acid sequence 1, a 3691 base pair sequence fully defined in the specification; (b) hybridizes under stringent conditions with all nucleic acid fragments 477-819, 820-3069 and 3070-3137 or the complementary nucleic acids; and (c) is capable of suppressing cell proliferation. Independent claims are also included for the following: (1) a recombinant expression vector (II) which is suitable for the expression of (I); (2) a recombinant polypeptide (III) which suppresses cell proliferation and: (a) is coded by the DNA of sequence 1; (b) is coded by DNA sequences which hybridize under stringent conditions with all of the nucleic acid fragments 477-819, 820-3069 and 3070-3137; (c) is coded by DNA sequences which, if there was no degeneracy of the genetic code, would hybridize under stringent conditions with the sequences in (a) and (b); and (3) a method for the production of a protein which has tumor suppressive activity, by expressing an exogenous DNA in prokaryotic of eukaryotic host cells and isolation of the desired protein comprising DNA as in (2). ACTIVITY : Cytostatic. MECHANISM OF ACTION : Tumor suppressor.
Patent AT-E310940-T1 (AT)
Inventor: KLEMM HEINZ
IPC: G01C21/36
Filed: 1999-03-17
Granted: 2005-12-15
Abstract: The system has a readout memory, an input unit and an identifier, to transmit a dataset of signal sequences to a working memory. The signal sequences can be represented in a hierarchical branch structure with several planes. When a data set is transmitted, the part data are arranged in successive structural planes. Directly before the end of transmission of the entire dataset, the identifier accepts the logical linkage of a possible signal sequence with the yet incomplete working memory content.
Patent AT-E227925-T1 (AT)
Inventor: STECKELBERG JOACHIM DR
IPC: C09B62/51
Filed: 1999-08-18
Granted: 2002-07-15
Abstract: A dye mixture comprising one or more disazo dyes composed of 1-amino-3,6-disulfo-8-naphthol as the coupling component and of two diazo components of the aniline series containing each a fiber-reactive group of the vinylsulfone series, one or more monoazo dyes composed of a sulfo-substituted 2-amino-naphthalene as coupling component and a diazo component of the aniline series containing a fiber-reactive group of the vinylsulfone series, and optionally one or two monoazo dyes with 1-amino-3,6-disulfo-8-naphthol as a coupling component to which is coupled in the ortho-position to the amino group a diazo component of the aniline series substituted by a fiber-reactive group of the vinylsulfone series. The dye mixtures yield on hydroxy- and/or carboxamido-containing fiber, materials, such as cellulose fibers, in particular cotton, or on, for example, wool and synthetic polyamide fibers, deep black dyeings.
Patent AT-E258817-T1 (AT)
Inventor: OLSCHNOEGGER KURT
IPC: A63C5/00
Filed: 1999-10-20
Granted: 2004-02-15
Abstract: A board for sliding on for example snow, comprises a honeycomb type light weight core with numerous hollow chambers bordered by cell walls. The core (4) consists of an extended thermoplastic and the hollow chambers and cell walls are formed by stretching the plastic in the direction of the board thickness.
Patent AT-E257594-T1 (AT)
Inventor: CANTU GARY R
IPC: G01N23/04
Filed: 1996-06-19
Granted: 2004-01-15
Abstract: A system is provided for reading an image stored on a storage layer radiation screen. The system includes a carousel for holding a storage layer radiation screen and a screen scanning system. The screen scanning system includes a carousel mount on which the carousel may be mounted and a rotation mechanism for rotating the carousel mount, rotation of the carousel mount serving to rotate the carousel about a rotational axis which, in turn, causes the screens held on the carousel to move in a circular path about the rotational axis. The carousel is preferably removable from the carousel mount. The screen scanning system also includes an image acquisition optical system positioned adjacent the circular path of the screen, the image acquisition optical system including an excitation system for focusing an excitation beam on a portion of the screen to cause a light emission, and an emission collecting system for collecting the light emitted from the screen. The screen scanning system may further include an optics driver for moving the image acquisition optical system in a direction parallel to the rotational axis of the carousel. A method is provided for reading images stored on multiple storage layer radiation screens. The method includes attaching multiple storage layer radiation screens to a carousel, rotating the carousel about a rotational axis such that the screens move in a circular path about the rotational axis, focusing an excitation beam at a point on the circular path such that the portions of the screens passing the point on the circular path emit light, collecting the light emitted, and moving the point on the circular path on which the excitation beam is focused in a direction parallel to the rotational axis. <IMAGE>
Patent AT-E232390-T1 (AT)
Inventor: CORPET DENIS E
IPC: A61K31/765
Filed: 1999-05-05
Granted: 2003-02-15
Abstract: Use of a non-fermented osmotic laxative as an active agent for preparation of a medicinal product for treating and/or preventing colon and/or rectum cancers. A method of treating or preventing colon or rectum cancer comprising administering to a mammal a therapeutically effective amount of a non-fermented osmotic laxative.
Patent AT-E246352-T1 (AT)
Inventor: DUSSAULT RICHARD A
IPC: G01N33/49
Filed: 1999-05-12
Granted: 2003-08-15
Abstract: A sample cell for use in spectroscopy includes two cell portions that are mutually adjustable to enable a user to vary the cross sectional geometry of sample cell flow path thereof between at least two discrete configurations or positions. In a first position, the flow path may be provided with a relatively small cross-sectional area to provide a relatively small pathlength and generate high velocity fluid flow therethrough. The small pathlength enables use of relatively small sample volumes and facilitates optical measurement of samples, such as blood, which have relatively high optical density, absorbance or light scattering properties. In a second position, the flow path provides a larger cross-section adapted to permit larger agglomerations or clots to pass through the flow path to facilitate cleaning of the sample cell. The cell portions are maintained in slidable engagement with one another so that the adjustability of the flow path is accomplished by sliding movement of the cell portions relative to one another. In one embodiment, the cell portions are engaged along generally planar mating surfaces and the adjustability is accomplished by sliding the mating surfaces relative to one another. In another embodiment, the mating surfaces are superposed in spaced relation to one another, and the adjustability is accomplished by varying the distance therebetween.
Patent AT-E214654-T1 (AT)
Inventor: DIETZ HANS PROF DR
IPC: B27B1/00
Filed: 1999-06-18
Granted: 2002-04-15
Abstract: For use as a wood intermediary and the like in industry, an essentially wedge-shaped wood flake with opposite concave and convex surfaces that converge at an imaginary tip outside the flake dimensions. The tip is located beyond the flake a distance of typically between 40% and 100% of the flake length.
Patent AT-E281778-T1 (AT)
Inventor: BORZI ENZO
IPC: A47H13/00
Filed: 1999-07-02
Granted: 2004-11-15
Abstract: A sliding device for cloth stripes with bows for hanging up pelmet curtains and similar, consisting of a structure, preferably out of plastic material, with a concave portion of cylindric surface so as to fit to the corresponding shape of the support (B), and provided with one single upper eyelet (2) through which the ends of each couple of cloth stripes (F) are inserted, crossed and tied between each other so as to realize an upper bow (FO) and to completely eliminate the contact between the cloth of said cloth stripes and the material of the support, thus facilitating the lateral sliding of the curtain.
Patent AT-E246522-T1 (AT)
Inventor: GREEN TERRENCE R
IPC: A61K47/30
Filed: 1999-06-18
Granted: 2003-08-15
Abstract: There is disclosed a medical device for implantation that acts to prevent transmission of infectious agents. Specifically, the present invention provides implantable devices, such as catheters or living skin matrices or wound dressings, for insertion into various body cavities or over wound sites to confer to the site microbicidal or virucidal activity. Devices in the disclosure designed as vaginal inserts also exhibit contraceptive spermicidal activity. The coated devices or devices having the inventive polymeric material interspersed throughout are formed into appropriate shapes according to their contemplated uses (such as catheters or Foley catheters). Further, the present invention provides devices for providing therapeutic anti-microbial activity into an infected body cavity or on an infected wound site.
Patent AT-E297991-T1 (AT)
Inventor: ASAKAWA MAKOTO SHIONOGI
IPC: A61K48/00
Filed: 1999-08-10
Granted: 2005-07-15
Abstract: The present invention provides an RNA virus vector useful for gene therapy. The RNA virus vector is capable of cell infection, autonomous RNA replication, and infiltration through contact, but incapable of dessimination. The use of the RNA virus vector of the present invention enables more efficient gene transfer and cell transplantation in gene therapy compared with the conventional techniques. <IMAGE>
Patent AT-E399316-T1 (AT)
Inventor: NEMORI RYOICHI
IPC: G01N31/22
Filed: 1999-09-10
Granted: 2008-07-15
Abstract: A method for measuring a thiol group-containing compound, which comprises the steps of (1) contacting a sample containing a thiol group-containing compound with a thin membrane comprising a microparticle of a substance selected from the group consisting of a metal and a metal compound and comprising a hydrophilic binder; and (2) detecting a color change on the thin membrane resulting from interaction of the thiol group-containing compound and the microparticle, and a thin membrane used for said method. A thiol group-containing compound such as an alkylmercaptan or a protein containing thiol groups can be conveniently and accurately measured.
Patent AT-E248259-T1 (AT)
Inventor: KOIVUNEN KARI
IPC: E02D5/52
Filed: 1999-10-28
Granted: 2003-09-15
Abstract: The invention relates to a stiff joint for end to end jointing of precast concrete driven piles, each end of the precast concrete pile (P1, P2) of the joint comprising an end surface (10). The joining means comprise first planar joining loops (1) and second planar joining loops (2) forming a hole transverse to the longitudinal direction (Lp) of the piles and overlapping and located adjacent each other to form a joining space (9). The joining loop holes (3, 4) are mutually aligned (Lt) and a transverse locking pin (6) passes through them. Each joining space (9) comprises at least two first joining loops (1) at the end of the first pile (P1) and at least two second joining loops (2) at the end of the second pile (P2), and the joint comprises at least two such joining spaces disposed at a support distance from the central line (13) or bisectional plane of the pile.
Patent AT-E228254-T1 (AT)
Inventor: SCHUETZ HARTMUT
IPC: G05B9/02
Filed: 1999-09-14
Granted: 2002-12-15
Abstract: Device (1) for controlling and/or monitoring external technical processes, in particular a device for use in connection with safety-related controls. The device includes an input functionality, an output functionality and a processing functionality that can be connected with at least one higher-level unit (5) for transfer of process-influencing and/or process-monitoring signals by way of a bus system (4) to and/or from actuators (3) and/or sensors (2) connected to the device. A guaranteed response time over the bus system (4) is determined on one hand by the cycle time of the higher-level unit (5) and on the other by the signal cycle time over the bus system (4) itself. In order to provide a shorter response time than this in appropriate circumstances, the device (1) uses the processing functionality thereof to execute logical links internally. The results are available for process control and/or process monitoring after a time interval that is shorter than the guaranteed response time of the higher-level unit (5) over bus (4).
Patent AT-E332013-T1 (AT)
Inventor: STRECHENOK OLEG
IPC: A61K31/661
Filed: 1999-12-28
Granted: 2006-07-15
Abstract: It is shown that the potency of anti-cancer drugs, here exemplified by doxorubicin, can be increased by the use of polyunsaturated fatty acid amides and in particular specific combinations of such compounds, forming complexes with doxorubicin. Further, a modified form of doxorubicin is presented.
Patent AT-E277239-T1 (AT)
Inventor: RUUD ANDERS
IPC: E04B2/02
Filed: 1999-12-08
Granted: 2004-10-15
Abstract: A brick is made of refractory material, preferably for use in a furnace for calcining carbon bodies, wherein at least one surface of the brick that is facing towards an adjacent brick is provided with mating elements such as recesses and projections. The mating elements are rotationally symmetric about an axis that is perpendicular to the surface.
Patent AT-E356637-T1 (AT)
Inventor: DAVIS MARK E
IPC: A61K47/40
Filed: 1999-12-03
Granted: 2007-04-15
Abstract: A method of preparing a supramolecular complex containing at least one therapeutic agent and a multi-dimensional polymer network is described. A supramolecular complex prepared by a method of the invention is described. A method of treatment by administering a therapeutically effective amount of a supramolecular complex of the invention is also described. Such a supramolecular complex may be used as a delivery vehicle for various therapeutic agents.
Patent AT-E301977-T1 (AT)
Inventor: PREUSSNER PAUL ROLF DR
IPC: A61F2/48
Filed: 1999-12-28
Granted: 2005-09-15
Abstract: Disclosed is an implant for implantation in the human eye, which enables natural adjustment of the eye to different distances (accommodation) after cataract surgery (lens opacity). Permanent magnets (inner magnets) rest on the periphery of the intraocular lens located inside the capsular sack. Two additional permanent magnets that are fixed to the sclera (outer magnets) are located opposite to said inner magnets and slightly staggered to the back. The inner and outer magnets are polarized and geometrically disposed in such a way that they repel one another. Said repulsion effects a forward movement of the capsular sack and the lens located therein when the ciliary muscle contracts. Before placing the outer magnets, a measurement can be conducted with the aid of electromagnets whose strength can be regulated, whereby accommodation is determined as a function of the strength of the outer magnets. On the basis of the data obtained during said measurement, the strength, number, geometry and position of the outer (permanent) magnets can be selected.
Patent AT-E361752-T1 (AT)
Inventor: YLIKOSKI JUKKA
IPC: C07D487/04
Filed: 1999-09-24
Granted: 2007-06-15
Abstract: Methods for preventing or treating damage to sensory hair cells and cochlear neurons are disclosed. The methods comprise the administration of an effective amount of a compound of Formula I or Formula II. The method provides for the prevention/treatment of both hearing loss and loss of the sense of balance.
Patent AT-E240115-T1 (AT)
Inventor: SHOENFELD YEHUDA
IPC: A61K38/00
Filed: 1999-09-30
Granted: 2003-05-15
Abstract: An immunological oral tolerance-inducing composition for prevention and/or treatment of atherosclerosis, comprising an active component selected from the group consisting of modified low density lipoprotein, oxidized low density lipoprotein (Ox LDL), heat shock protein 60/65 (HSP 60/65), beta2-glycoprotein-1(?2GP-1), functional derivatives thereof and mixtures thereof, in combination with a pharmaceutically acceptable carrier for oral administration.
Patent DE-323491-T1 (DE)
IPC: F23L11/00
Filed: 1988-05-25
Abstract: A gas flow diverter receives large volumes of hot gazes from a gas turbine and has a blade adapted to close either the outlet port to a heat recovery steam generator or the outlet port to the stack. Each port is surrounded by an open channel the two side walls of which are each provided with a seal with both exposed, one beyond the other. The surfaces of the blade are stainless steel cladding and are connected through insulation to a reinforcement in a manner permitting but confining the expansion of the cladding. The frame has a border providing first and second ledges on each side which are spaced and positioned so that each may engage a different one of the two seals bordering an outlet port when closed thus establishing the channel as a closed passageway surrounding the closed port which may be sealed against leakage by die-charging sealing air into it. The blade is shifted between its two operative positions by means of a reversible drive including toggle joints connected to the blade reinforcement by a unit which is shiftable in response to forces exerted by the expanding or contracting toggle joints. <IMAGE>